Millions of Covid 19 vaccinations have already been administered in Saxony-Anhalt. However, only a few vaccinated people claim permanent health problems. An interim.
Halle (dpa/sa) - So far, 160 applications for the recognition of vaccination damage after Covid 19 immunizations have been submitted in Saxony-Anhalt - with more than 4.5 million vaccinations administered. By September 1, 153 people who were directly affected had applied for what is known as care for the injured under the Infection Protection Act, as a spokeswoman for the state administration office in Halle said when asked. Eleven applications were made by survivors.
Accordingly, a wide variety of temporary and permanent health disorders are specified. The spectrum ranges from tiredness, headaches and joint pains, skin rashes, vision, concentration and sensory disturbances to myocarditis (inflammation of the heart muscle), pulmonary embolism and stroke. Those are just examples.
Temporary health disorders lasting up to six months were recognized for three applications. In one application, permanent health problems lasting longer than half a year were recognized with a degree of damage of ten percent.
According to the state administration office, most applications have so far been rejected: so far, this has affected 68 applications from those directly affected and 5 applications from surviving dependents. The main reason is that the health disorders claimed could not be attributed to the vaccination. 91 applications are still being processed.
As the State Administration Office further announced, people with recognized vaccination damage and ongoing health damage are entitled to benefits under the Federal Health Care Act. Which services are specifically considered must be checked on a case-by-case basis. According to the information, a basic pension, care allowance or compensation for occupational damage are possible as cash benefits, depending on the degree of damage. For survivors, there could be funeral benefits, death benefits and survivor's pensions.
